APIDRA insulin glulisine (rbe) 100IU/mL 3mL injection cartridge

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f2902efe72aebba2
Product Name: APIDRA insulin glulisine (rbe) 100IU/mL 3mL injection cartridge
Artg Id: 99146
Artg Name: APIDRA insulin glulisine (rbe) 100IU/mL 3mL injection cartridge
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2005-05-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a63042cf423fb3df3be10b37e5dd397b.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/8fc10c65f158c7ac80ef795ec9e511ae.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

f2902efe72aebba2

Type

Standard